Search Results
… Summary of advances : The epilepsies are a group of disorders with diverse causes and clinical presentations. … subsequent cognitive deficits [84]. As epilepsy is a disorder highlighted by synchronous activation of neurons, it …
… please visit: https://iprcc.nih.gov/FPRS/FPRSPublicComment.htm . You can also tune in to the Annual NIH Pain Consortium … improving public health surveillance on opioid abuse disorders, overdose, and death; support of cross-cutting … directions in preventing and treating opioid use disorders and overdoses, expedite the screening and …
… michael.ward4@nih.gov 301-594-6017 Dr. Ward received his B.S. from Kenyon College in 1999 and M.D. and Ph.D. degrees from Washington University in St. … H, Schiavo G, Fischer E, Raj T, Secrier M, Lashley Tm, Ule J, Buratti E, Humphrey J, Ward ME* , Fratta P. TDP-43 loss …
… supplements to active National Institute of Neurological Disorders and Stroke ( NINDS ) grants. Its purpose is to …
… and was involved in research on Progressive Multifocal Leukoencephalopathy (PML) as well as neurological … diseases, with particular focus on progressive multifocal leukoencephalopathy (PML) and the study of virological and … I. Portable ultra-low-field MRI for progressive multifocal leukoencephalopathy: Case studies, sensitivity, and potential …
… the central nervous system called progressive multifocal leukoencephalopathy or PML. PML is caused by the JC virus, a … Nath A. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.(external link) N Engl J Med. … T cells for immunotherapy of progressive multifocal leukoencephalopathy: an open-label, single-cohort pilot …
What are milestones?
A milestone is a finding or set of findings that signal the achievement of a specific aim in your research plan. Applicants must propose one or more milestones for each Specific Aim. For each milestone, provide sufficient details on methods, assumptions, experimental designs, data analysis plan (if the results are quantitatively measured), and specify the quantitative criteria for measuring success and related rationale. Quantitative criteria should be robust and consistent with the state-of-the-art in the…
… a process of equilibrium and a symbiotic relationship with the human genome and play important roles in … HERV-K subtype HML-2; both of which have been associated with neurodegenerative diseases. We are also interested in … viruses termed HERV-K (HML-2) is activated in patients with amyotrophic lateral sclerosis (ALS), and transgenic …
… of the design in situations where the “truth” is known, i.e ., an intervention is truly effective or not. … for enhancers and suppressors of genes already linked to PD to reveal new genetic steps in the known PD … cells, which properly query/model specific genetic defects linked with PD. Quantify protein modifications such as …
… Booklet Join Our Listserv For the most current updates on NINDS activities related to ADRD, including upcoming … interventions are developed. NINDS collaborates with NIH ’s National Institute on Aging ( NIA ), the lead NIH … Research Milestones and Success Criteria ; Proceedings Article 2013 ADRD Summit 2013 FACA Report (pdf, 980 KB) ADRD …